Isofol Medical AB (publ) (ISOFOL.ST)
SEK 2.53
(3.06%)
SEK 2.53
(3.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -52.53 Million | -190.97 Million | -188.42 Million | -160.27 Million | -147.2 Million | -92.45 Million |
| Net Income | -37.07 Million | -159.75 Million | -200.25 Million | -188.99 Million | -161.58 Million | -83.12 Million |
| Depreciation & Amortization | 37 Thousand | 1.64 Million | 1.59 Million | 1.77 Million | 1.55 Million | 157 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.05 Million | -31.67 Million | 14.76 Million | 24.76 Million | 10.21 Million | 1.64 Million |
| Other non-cash items | -4.44 Million | -1.19 Million | -4.54 Million | 2.18 Million | 2.6 Million | -11.13 Million |
| Investing Cash Flow | 101 Thousand | - | - | 1000.00 | -324 Thousand | - |
| Investments in PPE | - | - | - | - | -324 Thousand | - |
| Acquisitions | 51 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 50 Thousand | - | - | - | - | - |
| Other Investing Activities | 101 Thousand | - | - | - | - | - |
| Financing Cash Flow | -50 Thousand | -1.68 Million | 450.47 Million | 150.01 Million | -243 Thousand | 5.1 Million |
| Debt repayment | - | -1.7 Million | -1.54 Million | -1.55 Million | -1.29 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 23 Thousand | 452.02 Million | 151.56 Million | 1.04 Million | 5.1 Million |
| Other Financing Activities | - | -1.68 Million | 450.47 Million | 150.01 Million | -243 Thousand | 5.1 Million |
| Accounts receivables | 21.23 Million | -504 Thousand | 9.86 Million | -14.05 Million | -3.61 Million | -3.66 Million |
| Accounts payables | -32.28 Million | -31.16 Million | 4.9 Million | 38.81 Million | 13.83 Million | 5.3 Million |
| Inventory | 32.28 Million | 31.16 Million | -4.9 Million | -38.81 Million | -13.83 Million | - |
| Other working capital | -32.28 Million | -31.16 Million | 4.9 Million | 38.81 Million | 13.83 Million | 5.3 Million |
| Cash at beginning of period | 190.53 Million | 379.44 Million | 116.39 Million | 126.98 Million | 272.89 Million | 357.33 Million |
| Cash at end of period | 138.14 Million | 190.58 Million | 379.44 Million | 116.39 Million | 126.98 Million | 272.89 Million |
| Capital Expenditure | - | - | - | - | -324 Thousand | - |
| Effect of forex changes on cash | 50 Thousand | 3.79 Million | 1 Million | -334 Thousand | 1.86 Million | 2.92 Million |
| Net cash flow / Change in cash | -52.38 Million | -188.86 Million | 263.05 Million | -10.59 Million | -145.91 Million | -84.43 Million |
| Free Cash Flow | -52.53 Million | -190.97 Million | -188.42 Million | -160.27 Million | -147.53 Million | -92.45 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.04 Million | -8.48 Million | -37.07 Million | -8.88 Million | -6.26 Million | -7.5 Million |
| Depreciation & Amortization | 1000.00 | 1000.00 | 37 Thousand | 1000.00 | 110 Thousand | 347 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.77 Million | 292 Thousand | -11.05 Million | 4.02 Million | -5.13 Million | 2.31 Million |
| Other non-cash items | -3.84 Million | -1.75 Million | -4.44 Million | -2.18 Million | -1.19 Million | -1.93 Million |
| Investing Cash Flow | - | - | 101 Thousand | 50 Thousand | 51 Thousand | 1000.00 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 51 Thousand | - | 51 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 50 Thousand | 50 Thousand | - | - |
| Other Investing Activities | - | - | 101 Thousand | 50 Thousand | 51 Thousand | - |
| Financing Cash Flow | - | - | -50 Thousand | 933 Thousand | -121 Thousand | -393 Thousand |
| Debt repayment | - | - | - | - | -121 Thousand | -393 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 933 Thousand | -121 Thousand | -393 Thousand |
| Accounts receivables | -108 Thousand | 96 Thousand | 21.23 Million | 4.69 Million | 306 Thousand | 4.72 Million |
| Accounts payables | 2.88 Million | 196 Thousand | -32.28 Million | -669 Thousand | -5.44 Million | -2.41 Million |
| Inventory | - | - | 32.28 Million | 670 Thousand | 5.44 Million | 2.41 Million |
| Other working capital | 2.88 Million | 196 Thousand | -32.28 Million | -670 Thousand | -5.44 Million | -2.41 Million |
| Cash at beginning of period | 128.49 Million | 138.14 Million | 190.53 Million | 144.22 Million | 156.76 Million | 163.96 Million |
| Cash at end of period | 119.15 Million | 128.49 Million | 138.14 Million | 138.14 Million | 144.22 Million | 156.76 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -1000.00 | 3000.00 | 50 Thousand | 26 Thousand | 6000.00 | -25 Thousand |
| Net cash flow / Change in cash | -9.34 Million | -9.65 Million | -52.38 Million | -6.07 Million | -12.54 Million | -7.19 Million |
| Free Cash Flow | -9.34 Million | -9.65 Million | -52.53 Million | -7.03 Million | -12.47 Million | -6.77 Million |
LGMH
8430
JSWHL
ARNOLD
603042
3283